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Abstract
BACKGROUND: The transcription factor STAT3 is a downstream target of the LIF signalling cascade.
LIF signalling or activation is sufficient to maintain embryonic stem (ES) cells in an undifferentiated
and pluripotent state. To further investigate the importance of STAT3 in the establishment of ES cells
we have in a first step derived stable pluripotent embryonic stem cells from transgenic FVB mice
expressing a conditional tamoxifen dependent STAT3-MER fusion protein. In a second step,
STAT3-MER overexpressing cells were used to identify STAT3 pathway-related genes by expression
profiling in order to identify new key-players involved in maintenance of pluripotency in ES cells.
RESULTS: Transgenic STAT3-MER blastocysts yielded pluripotent germline-competent ES cells at a
high frequency in the absence of LIF when established in tamoxifen-containing medium. Expression
profiling of tamoxifen-induced transgenic FVB ES cell lines revealed a set of 26 genes that were
markedly up- or down-regulated when compared with wild type cells. The expression of four of the
up-regulated genes (Hexokinase II, Lefty2, Pramel7, PP1rs15B) was shown to be restricted to the inner
cell mass (ICM) of the blastocysts. These differentially expressed genes represent potential candidates
for the maintenance of pluripotency of ES cells. We finally overexpressed two candidate genes,
Pem/Rhox5 and Pramel7, in ES cells and demonstrated that their overexpression is sufficient for the
maintenance of expression of ES cell markers as well as of the typical morphology of pluripotent ES
cells in absence of LIF. CONCLUSION: Overexpression of STAT3-MER in the inner cell mass of
blastocyst facilitates the establishment of ES cells and induces the upregulation of potential candidate
genes involved in the maintenance of pluripotency. Two of them, Pem/Rhox5 and Pramel7, when
overexpressed in ES cells are able to maintain the embryonic stem cells in a pluripotent state in a LIF
independent manner as STAT3 or Nanog.
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Abstract
Background: The transcription factor STAT3 is a downstream target of the LIF signalling cascade. LIF
signalling or activation is sufficient to maintain embryonic stem (ES) cells in an undifferentiated and
pluripotent state. To further investigate the importance of STAT3 in the establishment of ES cells we have
in a first step derived stable pluripotent embryonic stem cells from transgenic FVB mice expressing a
conditional tamoxifen dependent STAT3-MER fusion protein. In a second step, STAT3-MER
overexpressing cells were used to identify STAT3 pathway-related genes by expression profiling in order
to identify new key-players involved in maintenance of pluripotency in ES cells.
Results: Transgenic STAT3-MER blastocysts yielded pluripotent germline-competent ES cells at a high
frequency in the absence of LIF when established in tamoxifen-containing medium. Expression profiling of
tamoxifen-induced transgenic FVB ES cell lines revealed a set of 26 genes that were markedly up- or down-
regulated when compared with wild type cells. The expression of four of the up-regulated genes
(Hexokinase II, Lefty2, Pramel7, PP1rs15B) was shown to be restricted to the inner cell mass (ICM) of the
blastocysts. These differentially expressed genes represent potential candidates for the maintenance of
pluripotency of ES cells. We finally overexpressed two candidate genes, Pem/Rhox5 and Pramel7, in ES
cells and demonstrated that their overexpression is sufficient for the maintenance of expression of ES cell
markers as well as of the typical morphology of pluripotent ES cells in absence of LIF.
Conclusion: Overexpression of STAT3-MER in the inner cell mass of blastocyst facilitates the
establishment of ES cells and induces the upregulation of potential candidate genes involved in the
maintenance of pluripotency. Two of them, Pem/Rhox5 and Pramel7, when overexpressed in ES cells are
able to maintain the embryonic stem cells in a pluripotent state in a LIF independent manner as STAT3 or
Nanog.
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ES cell lines that maintain their pluripotency after trans-
fection and selection procedures are essential for the
introduction of selected targeted mutations into the
mouse germ-line. Pluripotent ES cells are established in
vitro from the inner cell mass (ICM) cells of explanted
blastocyst-stage embryos [1-3]. Murine ES cells are main-
tained in a pluripotent state by co-culturing with mitoti-
cally-inactivated feeder cells, such as embryonic
fibroblasts, and/or the addition of leukaemia inhibitory
factor (LIF: [4,5]). These ES cells can be maintained indef-
initely in the presence of LIF, and express markers of the
undifferentiated and pluripotent state, including the
POU-domain transcription factor OCT-3/4 (POU5F1), a
factor that is essential for the development of the ICM
(reviewed by [6]; [7]). Upon removal of LIF, the cells rap-
idly lose self-renewal capacity and differentiate into a vari-
ety of cell types. LIF belongs to the Interleukin-6 family of
cytokines and the members of this family have diverse
effects on a variety of cell types [8]. The shared usage of
signal transducers (i.e. gp130) in the multichain cytokine
receptor complexes clearly explains the functional redun-
dancies of these cytokines (reviewed by [9]).
The pathway by which LIF signalling acts to promote ES
cell self-renewal has been partially well studied (reviewed
by [10]). LIF signals via heterodimerization of the two
class I cytokine receptors, the low affinity LIF receptor
(LIFR) and the common subunit, gp130. The cytoplasmic
domain of gp130 contains several tyrosinase residues that
are phosphorylated by associated JAK (Janus kinase)
kinases after ligand-stimulated dimerization. Four of
these phosphorylated tyrosines have been identified as
putative interaction sites with the SH2 (Src homology 2)
domain of the transcription factor STAT3 (signal trans-
ducer and activator of transcription; [11]). Stimulation of
gp130 signalling in ES cells also phosphorylates SHP-2
(SH2-domain-containing tyrosine phosphatase) and
leads to activation of the mitogen-activated protein
(MAP) kinases ERK1 and ERK2 [12]. Inhibition of the
SHP-2/RAS/ERK pathway promotes self-renewal and sup-
presses differentiation and treatment of mouse ES cells
with the MAPK-inhibitor PD098059 [13] was shown to
enhance self-renewal [14].
Matsuda et al. (1999) have shown that activation of the
STAT3 transcription factor is sufficient to maintain mouse
ES cells in an undifferentiated state in the absence of LIF
[15]: An inducible transgene construct encoding the entire
STAT3 coding region fused to the mutated ligand-binding
domain of the estrogen receptor (STAT3-MER) was intro-
duced into ES cells. ES cells expressing the STAT3-MER
fusion protein maintained their undifferentiated state in
the presence of OHT and in the absence of LIF [15]. This
study highlighted the importance of STAT3 pathway in
maintenance of ES cell pluripotency in vitro. However, the
in vivo relevance of the LIF pathway is to date still not
clear; LIF expression can be detected in the trophectoderm
(TE) of the blastocyst whereas LIF receptor is expressed in
the ICM. However, neither LIF mutants [16] nor mutants
of the receptors LIFR [17,18] and gp130 [19] result in any
defects in the development of the ICM or early epiblast.
Recent evidence suggests that the LIF pathway is necessary
for survival of the mouse epiblast during diapause [20].
ES cell lines derived from different mouse strains exhibit
variable degrees of LIF dependency as demonstrated in
STAT3 gene targeting experiments by Raz et al. [21]. ES
cells heterozygous for a STAT3 mutation could only be
established from E14 cells (129P2/OlaHsd; [22]). Tar-
geted clones from other cell lines were invariably trisomic
for chromosome 11 that carries the STAT3 locus, and thus
retained normal levels of activated STAT3.
To date it is unclear if higher amounts of STAT3 in the
inner cell mass of blastocyst support the survival and der-
ivation of pluripotent ES cells, especially in so called non-
permissive mouse strains like FVB/N. The inbred mouse
strain FVB/N is widely used for the generation of trans-
genic animals [23], however only one germline compe-
tent ES cell line has been reported [24]. We therefore, in a
first step, generated FVB/N transgenic mice overexpressing
a tamoxifen inducible STAT3 (STAT3-MER). Our data
demonstrated that overexpression of STAT3 in the ICM of
the blastocyst supports the establishment of ES cells in the
FVB/N mouse strain. ES cell lines overexpressing STAT3-
MER were germline-competent whereas the only WT line
that we could establish was not germline-competent.
Recent studies have begun to identify key players involved
in the intracellular signal transduction pathways regulat-
ing stem cell renewal and proliferation. Several transcrip-
tion factors including the OCT-3/4 have been shown to be
essential to maintain pluripotency in the ICM, but none
had been shown to function independently of the LIF
pathway with exception of the newly identified home-
obox transcription factor Nanog, that directs pluripotency
in mouse ICM and mouse ES cells and functions inde-
pendently from LIF dependent STAT3 activation [25,26].
Nanog is detected in the ICM and early germ cells, as well
as in the ES and embryonic carcinoma (EC) cell lines
derived from these stages [25]. Overexpression of Nanog
relieves mouse ES cells cultured without feeder cells in the
presence of serum from dependence on LIF stimulation
for self-renewal whereas Nanog-deficient mouse ES cells
loose pluripotency and differentiate into extra embryonic
endoderm lineages [26].
We have further focused our study on the STAT3 pathway
in order to elucidate the differences between WT andPage 2 of 17
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formed microarray-analysis comparing WT and STAT3-
MER overexpressing FVB/N ES cells and identified a pool
of genes that were differentially expressed. From the
microarray dataset, we screened for potential candidates
of pluripotency by their expression pattern in the early
preimplantation embryo. Among these, we confirmed
Pem/Rhox5 and Pramel7 as regulators of pluripotency
using functional studies: ES cells overexpressing Pem/
Rhox5 and Pramel7 were able to maintain typical pluripo-
tent ES cell morphology in the absence of LIF, as well as
the characteristic pluripotency-related markers SSEA-1
and Oct4 in a similar extent as Nanog which was used as
a positive control. This clearly demonstrates that these
two STAT3-pathway related genes are involved in the
maintenance of pluripotency.
Results
Generation of transgenic mice overexpressing STAT3-MER
We produced FVB/N transgenic mice overexpressing a
fusion protein composed of the entire coding region of
mouse STAT3 and the modified ligand-binding domain
(G525R) of the mouse estrogen receptor [15]. The modi-
fied ligand-binding domain binds the synthetic steroid
ligand 4-hydroxytamoxifen (4OHT) but not 17β-estradiol
[30]. The expression of the transgene is driven by a
chicken β-actin promoter and therefore is expected to be
ubiquitously expressed. After injection of the construct
into the pronucleus of fertilized FVB/N eggs we obtained
seven positive founder animals. When crossed with wild-
type FVB/N partners, six of them showed germline trans-
mission. A multiple tissue analysis was performed, by
western blotting, in order to define animals exhibiting
ubiquitous expression (data not shown). Two of highest
STAT3-MER expressing lines (Tg741 and Tg743) were
selected for further experiments. Both transgenic lines
contained a single integration of the transgenic cluster and
were maintained in a hemizygous state by constant breed-
ing with WT FVB/N mice.
Overexpression of inducible active STAT3-MER enables 
the establishment of germline competent ES cells from 
FVB/N blastocysts
In order to test if the overexpression of STAT3-MER would
allow the establishment of germline competent ES cells
from the FVB/N mouse strain, morulae were flushed from
the uterotubal junction 3 days after mating and cultured
overnight in M16 medium (Sigma). Fully expanded blas-
tocysts were transferred onto MEF as described in "Meth-
ods". Full-grown ICMs were picked from the outgrown TE
and dissociated mechanically into groups of cells and
these aggregates reseeded onto embryonic feeder fibrob-
lasts. 3–4 days later, compact stem cell colonies could be
identified. Single colonies were dissociated as described
above and reseeded. Non-differentiating clonal lines were
further passaged and split after 2–3 generations for further
characterization. Embryos were cultivated in medium
containing either LIF or OHT. We were able to establish
both wild type and transgenic ES cell lines. However, even
if ICMs from WT embryos were able to outgrowth from
the TE in presence of OHT it was impossible to generate
ES cell colonies during the further steps of cultivation and
WT ES cells were only obtained when LIF was present in
the medium (Table 1). When using OHT-supplemented
medium without LIF 43–71% of the embryos from both
Tg741 and Tg743 transgenic lines yielded ES cell lines, all
of which were transgenic (Table 1). Because the mice used
were hemizygous for the transgene, and therefore only
50% of the embryos is expected to be transgenic, it is fair
to assume that we were able to derive ES cells from virtu-
ally all the transgenic embryos. These results strongly indi-
cate a supportive effect of active STAT3-MER on the
maintenance of pluripotent ES cells. The newly estab-
lished ES cell lines overexpressing STAT3-MER were culti-
Table 1: Establishment of FVB/N ES cells
Founder Line No Of embryos Medium Supplements No of ICM picked No of stem cell colonies Cell lines Transgenic
WT 15 LIF 8 (53%)* 5 (62%)** 5 -
15 OHT 4 (27%)* 0 (0%)** - -
741 28 OHT 23 (82%)* 10 (43 %)** 7 7 (100 %)#
743 28 OHT 14 (50%)* 10 (71 %)** 10 10 (100 %)#
741-F1 26 OHT 18 (69%)* 8 (44 %)** 8 8 (100 %)#
* percent ICM per plated embryo; ** percent colonies per picked ICM
# percent transgenic per cell lines
WT FVB/N or hemizygous FVB/N males carrying the STAT3-MER transgene (lines 741 and 743) were mated with WT FVB/N females. Blastocysts 
were cultivated either in presence of LIF or OHT. Outgrown ICM's were picked and cultivated till ES cell colonies were visible. Cells were tested 
for the presence of the transgene by PCR analysis. As expected it was possible to establish WT ES cells only in presence of LIF but not when OHT 
alone was added to the culture. Furthermore in presence of OHT both transgenic lines 741 and 743 generated ES cell colonies that were carrying 
the transgene. Because theoretically only 50% of the blastocysts were expected to be transgene it is to assume that the establishment frequency 
was almost 100%. After generation of germline competent chimera with the newly established 741 cell line hemizygous transgenic F1 animals were 
generated and mated with WT FVB/N females. In this breeding the establishment efficiency in presence of OHT was similar to one observed in the 
parental blastocysts indicating that the STAT3-MER induced stabilization is kept also in the F1 generation.Page 3 of 17
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order to confirm the pluripotency of these ES cells, karyo-
typically normal male cells from both transgenic lines
(Tg741 and Tg743) were injected into C57BL/6 host blas-
tocysts. Chimeric males were identified by the absence of
eye (pink) and coat (albino) pigmentation and mated to
wildtype FVB/N females. Germline transmission of the
FVB/N ES cell genome resulted in albino offspring (Figure
1D). None of the 5 FVB WT ES cell lines was able to pro-
duce chimeras when injected into C57BL/6 blastocysts
(data not shown). To confirm that overexpression of
active STAT3 supports the survival and derivation of
pluripotent ES cells also in the F1 generation, transgenic
germline F1 offspring from the line Tg741 were mated to
Characterization of the 743 transgenic ES cell lineFigure 1
Characterization of the 743 transgenic ES cell line. A. Phosphorylation/dephosphorylation analysis of Tyr705 in endog-
enous and transgenic STAT3. After 24 hours of LIF and OHT deprivation cells were cultivated till their homogenization in 
presence of either LIF or OHT. During LIF or OHT deprivation no changes in the protein expression levels could be detected, 
but after 24 hrs the Tyr705 residue of both transgenic and WT STAT3 was completely dephosphorylated. 10 minutes after 
addition of LIF the tyr705 residue of both STAT3 was phosphorylated whereas after addition of OHT complete phosphoryla-
tion was obtained only after 6 hrs. B. Dephosphorylation of Tyr705 was analyzed by eliminating LIF or OHT from respectively 
WT or 743 cells. Kinetics for the dephosphorylation were slower then for the phosphorylation, only after 48 hrs dephosphor-
ylation of WT Tyr705 was complete whereas complete dephosphorylation of STAT3-MER occurred only after 72 hrs. C. 
Nanog and STAT3 expression levels were tested by RTQ-PCR. Values are normalized with β-actin and the values indicate fold 
changes compared to the WT. Both WT and 743 ES cell lines expressed Nanog and the transgenic 743 ES cells have an 
increased Nanog expression compared to WT. D. After injection of 743 in C57BL/6 host blastocysts a 50–60% chimera was 
generated. Littermates from the crossing of the chimera with a WT FVB/N female generated white littermates, 50% of which 
were hemizygous for the transgene, indicating germline competence of the 743 cell line.Page 4 of 17
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and cultivated as previously described, if cultivated in
presence of OHT stem cell lines could be established from
44% of the embryos, all lines being transgenic (Table 1).
Characterization of the newly established FVB/N ES cells 
overexpressing STAT3-MER
The expression level of STAT3-MER in the ES clones
obtained from the line 743, was tested by western blot
(see Figure 1A and 1B). Upon LIF stimulation STAT3 is
phosphorylated on the tyrosine residue (Y705), dimerizes
and can bind DNA [31,32]. In order to test if OHT is able
to induce STAT3-MER phosphorylation FVB/N ES cells
expressing STAT3-MER were first deprived of LIF or OHT
for 24 hrs, after this time the Tyr705 residues of both the
endogenous STAT3 and STAT3-MER were completely
dephosphorylated. After the 24 hrs deprivation cells were
stimulated either with LIF or OHT for 10 minutes up to 24
hours and further cultivated in presence of LIF or OHT till
their homogenization. Cell extracts were separated by
SDS-PAGE, blotted and probed with anti-STAT3 and anti-
phospho (Y705) antibodies. LIF stimulation induced
tyrosine phosphorylation of both endogenous STAT3 and
STAT3-MER (Figure 1A). As previously observed [15],
endogenous STAT3 was rapidly phosphorylated whereas
phosphorylation kinetics of STAT3-MER were slower. In
ES cells derived from Tg743 stimulation with OHT
resulted in a strong tyrosine phosphorylation of STAT3-
MER, but only a limited phosphorylation could be
detected for endogenous STAT3 (Figure 1A). During the
24 hours of induction with either LIF or OHT expression
of Oct4 was confirmed (data not shown). Dephosphor-
ylation kinetic of Tyr705 was also analyzed by eliminating
LIF or OHT from the medium of respectively WT or 743
cells. Kinetics for the dephosphorylation were slower then
for the phosphorylation, only after 48 hrs dephosphoryla-
tion of WT Tyr705 was complete whereas complete
dephosphorylation of STAT3-MER occurred only after 72
hrs. Dose dependence for dephosphorylation could also
be observed. In ES cells derived from the Tg743 line,
expressing higher amounts of STAT3-MER, dephosphor-
ylation was slower compared to cells derived from the
lower expressing Tg747 line (data not shown).
ES cells overexpressing STAT3-MER express the typical 
ES-cell markers
ES cells, as well as cells of the ICM of mouse blastocysts,
express a panel of markers that are used to characterize
undifferentiated, pluripotent embryonic cells, between
them Nanog, alkaline phosphatase, OCT-3/4 and SSEA-1
are the most typically used. Nanog expression was tested
by RTQ-PCR; both WT and 743 ES cells expressed Nanog
and a light overexpression could be detected in the 743
cells if compared with WT cells after normalization with
the housekeeping gene β-actin (Figure 1C). The expres-
sion of the transcriptional factor OCT-3/4 and the surface
marker SSEA-1 was tested by immunohistochemistry (Fig-
ure 2A); WT FVB as well as both transgenic lines 743 and
741 expressed both markers. Furthermore, all three cell
lines expressed the marker alkaline phosphatase (Figure
2B). In all cases the expression was restricted to the ES
cells and no signal could be detected in the inactivated
fibroblast used as feeder cells.
Microarray analysis
Even though it was possible to establish WT FVB ES cells
in presence of LIF and these cells express the typical mark-
ers for ES cells they were not able to generate chimeric
mice. This suggests that overexpression of STAT3-MER
could increase the level of pluripotency in FVB ES cells. In
order to understand the difference between the WT cells
and the germline competent 743 cells we decided to com-
pare the gene expression profiles of both lines. We com-
pared three independently cultivated dishes of WT FVB
cells cultivated in the presence of LIF with three independ-
ently cultivated dishes of the transgenic 743 cells overex-
pressing STAT3-MER cultivated in the presence of OHT.
Total RNA was isolated and an expression analysis was
performed by hybridizing U74v2 Affymetrix chips con-
taining probes covering the complete mouse transcrip-
tome (36'000 transcripts). Analysis was performed with
dCHIP by using both the PM/MM (perfect match/mis-
match) difference model and the PM (perfect match) only
model in order to compare the results [33]. Genes show-
ing expression changes higher then 1.5 fold were consid-
ered. As control, we first confirmed that the
overexpression of STAT3-MER in the 743 line was 33
times higher than in the WT cells. We further identified a
set of 26 differentially regulated genes, 13 were upregu-
lated (Table 2) whereas 13 were downregulated (Table 3).
In situ Hybridization
In a first step we analyzed which of the differentially
expressed genes had already previously been described in
the literature to be expressed during preimplantation
mouse development and therefore potentially play a role
in maintenance of pluripotency. Eight genes out of the 26
identified were considered as candidates to have a poten-
tial function in determination and maintenance of
pluripotency in ES cells. For these genes in situ hybridiza-
tion was performed in order to define the regions of pre-
implantation embryos in which they were expressed. The
temporo-spatial expression was analyzed by whole mount
in situ hybridization of morulae and blastocysts. Four
genes, Pramel7, Lefty2, Protein Phosphatase 1 regulatory
subunit 15B and hexokinase II were expressed only in the
central part of the morula and in the ICM of the blastocyst
(Figure 3A). The other five genes, Pramel6, Eif2s2, Pem/
Rhox5, Dppa3 and Skp2 were found to be expressed in all
cells of the morula and blastocysts (Figure 3A). BecausePage 5 of 17
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Immunohistochemical analysis of WT, 741 and 743 ES cell linesFigure 2
Immunohistochemical analysis of WT, 741 and 743 ES cell lines. All three cell lines express the nuclear marker OCT-
3/4 and the surface marker SSEA-1 (A) and alkaline phosphatase (B). The expression of all markers was restricted to ES cells. 
Mouse fibroblast used as feeder cells are negative for OCT-3/4, SSEA-1 and alkaline phosphatase. Scale bar in both large and 
small panels: 100 μm.
BMC Developmental Biology 2008, 8:57 http://www.biomedcentral.com/1471-213X/8/57the Pramel7 expression was restricted to the central part of
the morula and in the ICM of the blastocyst, a more exact
analysis of the preimplantation stages was performed
(Figure 3B). Expression of Pramel7 starts at the compacted
morula stage, no expression could be detected in earlier
developmental stages indicating that this gene fulfils the
requirements for being a potential candidate involved in
maintenance of pluripotency. A similar expression pattern
can be observed for Nanog [25].
Overexpression of Pem/Rhox5 and Pramel7 is sufficient for 
maintenance of ES cells in the absence of LIF
In order to test if Pramel7 is able to maintain pluripotency
without direct activation of the STAT3 cascade through LIF
the full-length cDNA of Pramel7 was inserted in the pflox-
edNanog vector (see Chambers et al., 2003) instead of the
cDNA of Nanog, and the vector was electroporated in E14
ES cells. In parallel the full-length cDNA of Pem/Rhox5
was also cloned in the same way into the pfloxedNanog
vector. Pem/Rhox5 was previously described to play a role
in maintenance of pluripotency, but it is not yet known if
it is transcriptionally regulated through STAT3. As a con-
trol for the experiments the pfloxedNanog vector itself
was also electroporated in E14 cells. All electroporated
cells were selected with puromycin and resistant colonies
were picked and expanded. After testing for the presence
of the vectors by PCR the positive clones were analyzed by
real time PCR and the clones with the strongest expression
were used for further experiments. In order to test for the
capacity of maintaining pluripotency in absence of LIF,
the cells were cultivated for 8 days without addition of LIF
to the medium. After 8 days in culture IHC was performed
in order to detect the expression of OCT-3/4, SSEA-1 and
alkaline phosphatase (Figure 4). E14 WT ES cells started
after 4 days to differentiate and showed the typical flat-
tened morphology of differentiating cells (data not
shown), after 8 days the cells were completely differenti-
ated and no longer expressed OCT-3/4 and SSEA-1.
Nanog overexpressing cells as expected maintained their
pluripotent state also in absence of LIF. Both Pramel7 and
Pem/Rhox5 overexpressing clones showed a similar
behaviour as Nanog overexpressing cells. The colonies
maintained the typical round shaped morphology and
expression of OCT-3/4 and SSEA-1 was present indicating
that these two genes were able to maintain pluripotency
also in absence of LIF.
Table 2: Upregulated genes
Probe set Identifier RefSeq Chr MM/PM fold 
change
MM/PM p-value 
(t-test)
PM fold 
change
PM p-value 
(t-test)
RTQ-PCR fold 
change
98524_f_at X-linked myotubular 
myopathy gene 1 
(Mtm1)
NM_019926 X 1.87 0.018906 1.91 0.017234 n.d.
94375_at Hexokinase 2 (Hk2) NM_013820 6 1.6 0.018958 1.61 0.015899 1.79 ± 0.11
95545_at Insulin-like growth 
factor 1A (Igf1)
NM_010512 10 2.34 0.003079 1.6 0.007358 n.d.
98059_s_at lamin A (Lmna) NM_001002011 3 1.58 0.070634 1.47 0.035881 n.d.
95562_at Nuclear domain 10 
protein 52 (Ndp52)
NM_029755 11 2.66 0.065377 2.08 0.057843 6.72 ± 0.67
101368_at Reproductive 
homeobox 5 
(Rhox5/Pem)
NM_008818 X 1.68 0.029649 1.82 0.013529 3.64 ± 0.3
103470_at Pramel6 NM_178249 2 6.18 0.02356 4.14 0.027034 10.0 ± 0.37
93245_at Pramel7 NM_178250 2 3.51 0.051948 2.77 0.052927 8.51 ± 0.92
95609_at Protein phosphatase 
1, regulatory 
(inhibitor) subunit 
15b (Ppp1r15b)
NM_133819 1 1.6 0.024109 1.5 0.022545 1.56 ± 0.12
92232_at suppressor of 
cytokine signaling 3 
(Socs3)
NM_007707 11 1.75 0.053978 1.56 0.015837 2.34 ± 0.35
101449_at tripartite motif-
containing 41 
(Trim41)
NM_145377 11 - - 4.11 0.000819 1.07 ± 0.17
160365_at Eukaryotic 
translation initiation 
factor 2, subunit 2 
beta (Eif2s2)
NM_026030 2 1.98 0.040383 1.96 0.042002 1.80 ± 0.09
160420_r_at tubulin, alpha 3A 
(Tuba3a)
NM_009446 6 2.07 0.080906 1.93 0.078476 n.d.
Genes upregulated after STAT3-MER activation through OHT. Microarray values are given as fold changes ratios relative to normalization derived 
from dCHIP. 13 genes were found to be significantly upregulated when compared with WT FVB/N cells cultivated in presence of LIF. Only genes 
with a 1.5× fold increase were considered as significant. The mRNA expression levels (mean ± standard deviation, n = 3) of relative to FVB WT 
control cells were validated by real time PCR analysis, RTQ-PCR values are ratios relative to β-actin (housekeeper gene) expression. For all 
selected genes measured, RT-PCR corroborated the rank order of magnitude of expression measured on the microarrays. Calculations were 
performed with both the PM/MM (perfect match/mismatch) difference model and the PM (perfect match) only model in order to compare the 
results.Page 7 of 17
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ES cell lines derived from different mouse strains exhibit
variable degrees of LIF dependency and to date it was
unclear if higher amounts of STAT3 in the inner cell mass
of blastocyst could support the survival and derivation of
pluripotent ES cells in non-permissive mouse strains. Our
work indicates that the activation of the STAT3 pathway
during cultivation of blastocysts supports ICM outgrowth
and clearly favors the establishment of new ES cell colo-
nies in the so called non-permissive FVB mouse strain.
Even though we were able to establish WT FVB/N ES cells
in the presence of LIF these cells were not fully pluripotent
and were unable to generate chimeras. Only through the
overexpression of STAT3-MER cells we were able to estab-
lish germline competent FVB/N ES cells. Furthermore, in
presence of OHT both transgenic lines 741 and 743 gen-
erated ES cell colonies with a very high efficiency. Theoret-
ically only 50% of the blastocysts were expected to be
transgenic and this is also the establishment efficiency we
obtained. It is therefore fair to assume that the establish-
ment frequency was almost 100% (Table 1).
Interestingly no changes in the regulation of the classical
marker for pluripotent ES cells could be detected between
WT and 743 cells. Alkaline phosphatase, OCT-3/4, SSEA-
1 were correctly expressed in both wildtype and transgenic
ES cell lines (see Figure 2A and 2B). RTQ-PCR showed a
slight upregulation of Nanog in the 743 ES cells (Figure
1C). If this upregulation is due to a direct or an indirect
interaction with STAT3 has to be further analyzed. The dif-
ferent roles of the LIF pathways and of Nanog are yet not
very clear. ES cell populations are heterogeneous and it is
also known that Nanog is expressed discontinuously in
pluripotent cells in the embryo and it is therefore to
assume that Nanog and the LIF pathway interact to some
extent in controlling the different events that regulate
pluripotency and self-renewal. The recent findings of
Chambers et al. (2007) corroborate this hypothesis. The
authors demonstrated that Nanog expression was specifi-
cally required for both the formation of the ICM and of
the germ cells, rather than for the housekeeping machin-
ery of pluripotency embryonic, and that stem cells could
self-renew indefinitely in the permanent absence of
Nanog [34].
We were further interested in the identification of the
molecular changes induced through STAT3-MER overex-
pression. We therefore decided to identify STAT3-pathway
related genes by expression profiling. In general, there is
great interest in identifying the signature of stemness by
the constellation of genes that stem cells express. DNA
microarray technology allows the discovery of a large
number of genes that are thought to be the molecular sig-
nature of mouse ES cells. Recently, global transcription
profiles of undifferentiated ES cells and blastocyst have
been reported by several groups, most of these studies
were comparing differentiated versus undifferentiated
Table 3: Downregulated genes
Probe set Identifier RefSeq Chr MM/PM fold 
change
MM/PM p-
value (t-test)
PM fold 
change
PM p-value 
(t-test)
RTQ-PCR 
fold change
97283_at developmental pluripotency-
associated 3 (Dppa3)
NM_139218 6 -2.16 0.10982 -2.81 0.047749 -11.4 ± 1.51
133948_at Eukaryotic translation 
initiation factor 2C 4 (Eif2c4)
AI504948 17 -1.53 0.044727 -1.46 0.018363 n.d.
134566_at Left-right determination factor 
2 (Lefty2)
NM_177099 1 -2.7 0.029827 -2.32 0.025196 -2.35 ± 0.23
103389_at aminoadipate-semialdehyde 
synthase (Aass)
NM_013930 6 -2.07 0.077262 -1.71 0.100000 n.d.
167617_r_at transmembrane protein 109 
(Tmem 109)
NM_134142 19 -1.89 0.036619 -1.73 0.042999 n.d.
166131_at enabled homolog (Enah) NM_001083120 1 -1.55 0.008738 -1.46 0.016412 n.d.
138014_at nucleoporin 153 (Nup 153) NM_175749 13 -1.55 0.012282 -1.49 0.011324 n.d.
167824_f_at S-phase kinase-associated 
protein 2 (p45/Skp2)
NM_013787 15 -1.74 0.054672 -1.62 0.073491 -1.27 ± 0.03
100499_at syntaxin 3 (Stx3) NM_001025307 19 -2.09 0.033994 -2.03 0.036655 n.d.
166600_at KH domain containing, RNA 
binding, signal transduction 
associated 3 (Khdrbs3)
NM_010158 15 -1.66 0.027322 -1.52 0.035974 n.d.
93568_i_at 
93569_f_at
RIKEN cDNA 2610042L04 
gene
BC096548.1 14 -3.29 0.069938 -2.94 0.070848 n.d.
161004_at RIKEN cDNA 1700097N02 
gene
XM_001479022 17 -2.12 0.100000 -2.24 0.002726 n.d.
167843_f_at similar to RIKEN cDNA 
1110051B16 gene
XM_001472554 14 -2.71 0.004646 -1.81 0.003623 n.d.
Genes downregulated after STAT3-MER activation through OHT. 13 genes were found to be significantly downregulated when compared with WT 
FVB/N cells cultivated in presence of LIF. Only genes with a 1.5× fold decrease were considered as significant. The expression levels of selected 
genes were confirmed by real time PCR analysis. Calculations were performed with both the PM/MM (perfect match/mismatch) difference model 
and the PM (perfect match) only model in order to compare the results.Page 8 of 17
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In situ hybridization of the eight selected genesFigure 3
In situ hybridization of the eight selected genes. A. Dppa3, Eif2s2, Pem/Rhox5 and Pramel6 exhibited a general expres-
sion in all cells of the morula and of the blastocyst. Expression of Hexokinase II, Lefty2 and PP1s15B was restricted to the cells 
of the inner part of the morula and to the ICM in the blastocyst. Sense probes in the same concentration of the antisense 
probes were used as negative controls for the hybridization. B. In situ hybridization with a Pramel7 antisense riboprobe of pre-
implantation embryos (a: two-cell embryo, b: four-cell embryo, c: eight-cell embryo; d, e: compacted morula, f, g: blastocyst, h: 
negative control with sense riboprobe). Magnification 40×.
BMC Developmental Biology 2008, 8:57 http://www.biomedcentral.com/1471-213X/8/57cells [35-38]. In our study the FVB/N WT cells and the
FVB/N cells overexpressing STAT3-MER are very similar,
they just express different amounts of the transcription
factor STAT3 and therefore we assumed that they would
differentially regulate only a few genes. We compared
gene expression changes between FVB/N ES cells overex-
pressing activated STAT3 cultivated in the presence of
OHT and the absence of LIF and WT FVB cells cultivated
in the presence of LIF by microarray analysis and identi-
fied a group of 26 genes that showed significant differen-
tial expression. From this list we preselected interesting
genes by a careful literature and gene-expression databank
analysis and identified which genes were characteristically
expressed during the mouse preimplantation develop-
ment.
These genes can be attributed to different categories
according to their function: The first group contains regu-
latory members of the STAT3 pathway that are involved in
the regulation of downstream events of the JAK/STAT cas-
cade (like SOCS-3, protein phosphatase-1 regulatory sub-
unit 15B and Eif2s2), the second group of genes is
involved in the regulation of ES cell metabolism, whereas
the third group contains genes that are involved in
pluripotency maintenance and cell viability.
In the first group, among others, we found upregulation
of SOCS-3 in STAT3-MER overexpressing cells. SOCS3 is a
member of the suppressor of cytokine signalling (SOCS)
family which has been implicated in the negative regula-
tion of several pathways, in particular the JAK/STAT path-
way, which can in turn induce SOCS expression and form
a negative feedback circuit. The transcriptional upregula-
tion of SOCS-3 confirms that the functional overexpres-
sion of STAT3-MER induces the activation of the classical
LIF-dependent negative feedback mechanism (for a
review see [39]). Previously Duval et al. (2000) showed
that expression of SOCS-3, but not SOCS-1 and SOCS-2,
was stimulated in ES cells in presence of LIF. The author
further demonstrated that, uncontrolled overexpression
Immunohistochemical analysis of WT E14 ES cells and E14 overexpressing, Nanog, Pem and Pramel7Figure 4
Immunohistochemical analysis of WT E14 ES cells and E14 overexpressing, Nanog, Pem and Pramel7. IHC 
analysis with OCT-3/4 and SSEA-1 and staining for alkaline phosphatase were performed after cultivation of the cells for 8 days 
without adding LIF to the medium. E14 ES cells differentiated under these conditions and lost the expression of OCT-3/4 and 
SSEA-1 and alkaline phosphatase. Both Pem/Rhox5 and Pramel7 overexpressing cells maintained the expression of the pluripo-
tency markers. Nanog overexpressing cells, used as a control for the experiment, as expected maintained their pluripotency. 
Scale bar in both large and small panels: 100 μm.Page 10 of 17
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tion and severely reduces cell viability. This suggests that
the disturbance of a well-balanced SOCS protein content
has adverse effects on cell survival [40]. Since the FVB ES
cells overexpressing STAT3-MER were viable and pluripo-
tent, it is safe to assume that the SOCS-3 upregulation
observed in presence of OHT is a modulatory reaction due
to the overproduction of STAT3 in these cells. Through
this compensatory mechanism the cells are able to main-
tain a properly activated LIF signalling cascade. It seems
that the upregulation of SOCS-3 is a direct transcriptional
activation mediated through STAT3 because the promot-
ers of both mouse and rat SOCS-3 genes contain putative
STAT1/STAT3 binding elements, which are necessary and
sufficient for LIF-dependent activation of the SOCS-3 pro-
moter activity in reporter assays [41,42].
We also found protein phosphatase 1 regulatory subunit
15B (PP1rs15B) and the elongation initiation factor 2
subunit 2 (eIF2s2) to be among the upregulated genes.
PP1rs15B is a constitutively expressed inhibitory subunit
of PP1, one of the major eukaryotic serine/threonine
phosphatases. PP1rs15B dephosphorylates the α-subunit
of eIF2 [43]. The microarray data confirm an upregulation
of both PP1rs15B and eIF2s2 indicating that these pro-
teins may be involved in the control of the STAT3 overex-
pression, whether these genes have a function in
maintenance of pluripotency is still unclear.
In the second group we found hexokinase II to be
increased in cells overexpressing STAT3, this confirms the
importance of this isozyme for embryo viability and indi-
cates that a correct energetic balance is extremely impor-
tant in the late stages of preimplantation and at the
beginning of postimplantation in the embryos.
The third group of differentially expressed genes com-
prises molecules involved in the maintenance of pluripo-
tency and cell viability. Some of the identified genes were
previously correlated with pluripotency [44] or with
embryo viability in somatic nuclei derived cloned blasto-
cysts [45].
Lefty2 is regulated by pathways such as Smad2/3 and
WNT and by OCT-3/4, which support stemness. Lefty is
also induced upon exit from the state of stemness, includ-
ing forced in vitro differentiation and LIF withdrawal.
When LIF is withdrawn, the expression of Lefty increases
within 48 hours of cytokine withdrawal [37]. Similarly,
retinoic acid that induces differentiation leads to
increased expression of Lefty in mouse embryonic carci-
noma cells [46]. Differentiation of stem cells to embryoid
bodies also leads to increased expression of Lefty in vitro
[47]. Therefore, Lefty might be important both to the
stemness and differentiation events that follow the exit
from this state.
Murine Pem/Rhox5 is an X-linked homeobox-containing
gene [48,44], whose homeodomain shares important
structural features with two other homeobox genes, which
are expressed in extra embryonic lineages and during sper-
matogenesis [49,50]. The Pem/Rhox5 protein is expressed
in the late morula stage, in TE and ICM of blastocyst and
after implantation in extra embryonic tissues, in the pari-
etal and visceral endoderm, but not in the primitive ecto-
derm derivatives. Pem/Rhox5 is also expressed in ES cells,
in primordial germ cells and in teratocarcinoma cell lines
[51]. Overexpression of Pem/Rhox5 had no phenotype in
ES cells, but completely inhibited differentiation into the
three primary cell lineages, when ES cells were cultured as
embryoid bodies in suspension without LIF [52]. Two dif-
ferent models of action for Pem/Rhox5 are possible. Fan
et al. (1999) suggested that Pem/Rhox5 first helps to
maintain the undifferentiated cell state, and in a second
step promotes a defined cell population of undifferenti-
ated stem cells for differentiation into extra embryonic
lineages [52]. Sasaki et al (1991) proposed an alternative
in which Pem/Rhox5 directs early differentiation to spe-
cific lineages, but does maintain actively the undifferenti-
ated state [44]. Our data are in line with previous studies
and indicate that Pem/Rhox5 plays an important role in
maintaining pluripotency of ES cells in absence of LIF
(Figure 4)
Furthermore, overexpression of STAT3-MER induced dif-
ferential expression of four genes (Dppa3, NDP52l1,
Pramel6, Pramel7) that were identified as a set of OCT-3/
4 related genes that were not correctly reactivated in
somatic nuclei derived cloned embryos and therefore rep-
resent genes that are necessary for embryo viability [45].
Dppa3 (developmental pluripotency-associated 3; Stella;
PGC7; Crg1) is preferentially expressed in primordial
germ cells, oocytes and preimplantation embryos. In blas-
tocysts, Dppa3 is expressed in TE and ICM and in the early
postimplantation embryos Dppa3 expression disappears.
The expression re-emerges when at day E7.5 the first pri-
mordial germ cells (PGCs) appear [53]. Dppa3 knockout
mice are compromised in development; some embryos
develop to the two or four cell stage, but fail to reach 8-cell
stage [45,54]. Dppa3 was proposed by Sato et al. to play a
role in germ line specification in mice by preventing nas-
cent germ cell populations from a somatic cell fate and by
retaining their pluripotency [53]. The embryonic function
of NDP52l1 (Nuclear dot protein 52) is to date unclear
but it is capable of forming dimers and contains leucine
zipper motifs indicating a possible function in splicing
processes [55].Page 11 of 17
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melanoma like 6 and 7) are prevalently expressed in pre-
implantation embryos and embryonic pluripotent cells
[45]. Our results confirm these expression patterns and
clearly show that whereas Pramel6 is typically expressed
in all cells of the morula and blastocyst, Pramel7 is
expressed only in the inner part of the morula and in the
ICM of the blastocyst. The function of the Pramel genes in
embryonic development is unknown, but interestingly,
PRAME inhibits retinoic-acid induced differentiation in
mouse embryonic carcinoma F9 cells [56]. Recently Kaji et
al (2006) showed that Pramel6 and Pramel7 expression is
mediated by Mbd3, a component of the nucleosome
remodelling and histone deacetylation (NuRD) complex
[57]. Kaji et al. proposed that the Mbd3/NuRD-mediated
silencing of Pramel6 and Pramel7 in ES cells offers an epi-
genetic environment in which Mbd3/NuRD is not abso-
lutely required but facilitates differentiation. Furthermore
the authors describe that Mbd3 deficiency leads to down
regulation of Dppa3 in ES cells. Taken altogether, expres-
sion pattern analysis suggests that Dppa3, Pramel6 and
Pramel7 are collaborating in deciding the fate of ES cells.
We were further interested in clarifying if some of the
identified STAT3-pathway related genes could individu-
ally maintaining pluripotency in ES cells. Pem/Rhox5 and
Pramel7 were chosen for this experiments: Pramel7
because of its characteristic expression pattern in the cen-
tral part of the morula and in the inner cell mass of the
blastocyst, an expression pattern which is very similar to
the one observed for Nanog [25] and is typical for a gene
involved in maintenance of pluripotency. Pem/Rhox5
because it was previously described in the literature as a
gene blocking the differentiation capacity of the ICM and
of ES cells [52,51]. Overexpression of Pramel7 and Pem/
Rhox5 in ES cells and cultivation in absence of LIF,
allowed the maintenance of pluripotency, as shown by
IHC with the typical pluripotency related markers OCT-3/
4 and SSEA-1 and with alkaline phosphatase staining,
indicating the importance of these proteins in maintain-
ing ES cells in a pluripotent state (Figure 4).
Conclusion
In summary the data presented here indicates that the
overexpression of functional STAT3-MER in FVB/N blast-
ocysts sustains and facilitates the establishment of germ-
line competent ES cells in absence of LIF. Our findings
open up the possibility of establishing germline compe-
tent ES cells from non-permissive mouse strains by
manipulation of the STAT3 signal transduction pathway.
Furthermore, gene expression analysis of these transgenic
cells cultivated in presence of OHT showed that 26 genes
were differentially expressed compared to WT cells culti-
vated in presence of LIF. By in situ hybridization analysis
it was possible to identify four up-regulated genes (Hex-
okinase II, Lefty2, Pramel7, PP1rs15B) whose expression
was restricted to the ICM of the blastocysts. Overexpres-
sion of two of the upregulated genes, Pem/Rhox5 and
Pramel7, in E14 cells and cultivation in absence of LIF
demonstrated that these two genes are able to maintain
the embryonic stem cells in a pluripotent state without
addition of LIF to the culture media.
Methods
Generation, Identification, and Maintenance of 
Transgenic Mice
The pCAGmusstat3ER plasmid containing the full length
sequence of murine STAT3 cDNA fused to the ligand-
binding domain of mouse estrogen receptor under the
control of the chicken β-actin promoter [15] was propa-
gated in Escherichia coli DH5α and the minigene was
excised with NotI. The fragments were purified from a 1%
agarose gel with a Qiaquick extraction kit (Qiagen, Basel,
Switzerland) and processed as described. Nuclear injec-
tions into fertilized FVB/N oocytes were carried out by
conventional methods [27,28]. Transgenic founder were
identified by PCR using the β-actin promoter specific
primer ggbactfor2: (5'-GGG TTC GGC TTC TGG CGT G-
3') and a STAT3 specific primer mmSTAT3back2: (5'-CCA
AGG TGC CAG GAA CTG CCG-3'). Two primers specific
for the TAG-1 gene (TAG82B: 5'-ACA CGA AGT GAC GCC
CAT CCG T-3'; TAG83F: 5'-GGA GGA GAG AGA CCC
CGT GAA A-3') were used as a positive control for both
wild-type and transgenic mice. ggbactfor2 and
mmSTAT3back2 generate a 397 bp band whereas TAG82B
and TAG83F generate a 300 bp product.
Cell culture
ES Cell Medium for FVB/N ES cells
KSR-KDMEM (Invitrogen) with 1000 units per ml human
LIF, KSR-KDMEM w/o LIF and KSR-KDMEM w/o LIF with
1 μM 4-hydroxytamoxifen (OHT, Sigma).
ES Cell Medium for E14 ES cells
G-MEM (Sigma) containing 100 mM sodium pyruvate
(GIBCO), 10%FBS, 50 mM β-mercaptoethanol and con-
taining 107 U/ml ESGRO murine LIF (Chemikon Int.).
Embryonic feeder fibroblasts (MEF)
were derived from explanted day 14 foetuses of CD-1-M-
TKneo strain mice [29]. Prior to co-culturing with ES cells,
confluent layers of MEF (passage 2) cells were treated with
mitomycin C (10 μg/μl) for 2.5 hrs and extensively
washed. Growth arrested fibroblasts were used as feeder
cells for up to one week.
Embryo recovery, embryo culture, isolation of ES cell lines
Donor females of strains FVB/N (RCC Füllinsdorf, Swit-
zerland and Harlan Horst Postbus, Netherlands) were
induced to ovulate by an intra peritoneal injection of 5Page 12 of 17
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gon, Intervet), followed 46 h later by an intra peritoneal
injection of 5 I.U. HCG (human chorionic gonadotropin:
Chorulon, Intervet). Subsequently, donor females were
mated with STAT3-MER transgenic male mice. Morulae
were flushed from the uterotubal junction 3 days after
mating and cultured overnight in M16 medium (Sigma).
Fully expanded blastocysts were transferred onto MEF in
KSR-KDMEM, KSR-KDMEM without LIF with 1 μM OHT
or KSR-KDMEM without LIF and cultured at 37°C in an
atmosphere of 10 % CO2 in air for 6–7 days without
media changes. Full-grown ICMs were picked from the
outgrown TE and transferred into droplets of trypsin-
EDTA solution (Invitrogen) by a mouth-controlled glass-
capillary. The ICMs were dissociated mechanically into
groups of cells and these aggregates reseeded onto embry-
onic feeder fibroblasts. 3–4 days later, compact stem cell
colonies could be identified. Single colonies were dissoci-
ated as described above and reseeded. Subsequently, non-
differentiating clonal lines were partly frozen, partly pas-
saged onto 6 cm plates, and split after 2–3 generations for
further characterization.
Karyotype and Sex Determination of ES cell lines
For chromosome counts, ES cells were pre-treated for 3
hrs with colcemide (Sigma, 0.05 μg/ml) and metaphase
spreads were prepared according to Triman et al. (1975).
Sex determination was carried out using primers specific
for the smcy (Selected Mouse cDNA on Y) a gene that
maps to the short arm of the mouse Y-chromosome and
its X-chromosome homolog smcx (Selected Mouse cDNA
on X). The primers bind to both homologues but amplify
fragments of different sizes on the X and the Y chromo-
some. Female cell lines exhibit a single band of 341 bp
whereas male cell lines exhibit 2 bands of 341 and 312 bp
respectively. The following primers were used: SMC4-1:
5'-CTG AAG CCT TTG GCT TTG AGC AAG CTA C-3';
SMCX-1: 5'-CAA AGA ATT TGG CAG CGG TTT CCC T-3'.
Generation of injection chimeras
C57BL/6 host embryos were recovered at the morula stage
from the oviducts of hormonally treated females and cul-
tured overnight (see above). Blastocysts were transferred
into drops of M16 medium (Sigma) and ES cells into
drops of HEPES-buffered ES-medium. About 10–15 ES-
cells were injected into each blastocyst. After a recovery
period of about 2 hrs, injected blastocysts were transferred
into the uterine horns of pseudo pregnant NMRI foster
mothers (Harlan, England). Chimeric offspring were
identified by the absence of coat color pigmentation. Chi-
meric males were set up to breed at the age of about 8
weeks.
Western Blotting
ES cell cultures were homogenized with RIPA buffer (50
mM Tris-Cl pH 7.4, 1% NP-40, 0.25% Sodium Deoxycho-
late, 150 mM NaCl). Protein concentration was deter-
mined with BCA-Method (Pierce). Samples were
subjected to SDS-PAGE and blotted onto PVDF mem-
branes (Millipore, Volketswil, Switzerland) at 100 V for
1–2 h at 4°C. Immunodetection and chemiluminescent
visualization were performed as recommended by the
supplier of the chemiluminescence blotting kit (Roche
Diagnostics, Rotkreuz, Switzerland). Anti STAT3 antibody
(C-20) was purchase from Santa Cruz Biotechnology,
anti-phospho (Y705) was purchased from New England
Biolabs.
Immunohistochemistry and alkaline phosphatase staining
For alkaline phosphatase staining the cells were washed
with CMF-PBS and fixed in 4% paraformaldehyde in PBS.
The cells were washed with PBT (PBS with 0.1% triton X)
and incubated in alkaline phosphatase buffer (100 mM
Tris-Cl pH9.5, 50 mM MgCl2, 100 mM NaCl) containing
the AP-substrates nitrotetrazolium-blue and X-phosphate
(Roche Diagnostics, Rotkreuz, Switzerland).
For immunohistochemistry the cells were washed in PBS
and fixed with 4% paraformaldehyde in PBS. Cells were
washed with PBT and incubated with the primary anti-
bodies diluted in PBT containing 2% (v/v) horse serum.
Secondary fluorescence labelled antibodies were used for
detection. Anti OCT-3/4 (N-19) antibodies were pur-
chased by Santa Cruz Biotechnology, SSEA-1 (Mouse
mAb) by Chemicon International and Alexa Fluor 488
anti mouse and Alexa Fluor 594 anti rabbit secondary
antibodies were purchased from Molecular Probes.
cRNA labelling and Hybridization of microarrays
cDNA synthesis 1st round of amplification
RNA was combined with 1 μg of T7-dT primer (5'-GGC
CAG TGA ATT GTA ATA CGA CTC ACT ATA GGG AGG
CGG-(dT)24-3') in a total volume of 12 μl and incubated
at 70°C for 10 min. The reaction was placed on ice and
the following reagents added in a total volume of 20 μl:
first strand buffer (1×), DTT (10 mM), dNTP mix (500
μM), and Superscript III (200 units, Invitrogen) and incu-
bated at 42°C for 2 h. Second strand synthesis was per-
formed by adding the following reagents in a total volume
of 150 μl: second strand buffer (1×), dNTP mix (200 μM),
E. coli DNA ligase (10 units), E. coli DNA polymerase (40
units), RNase H (2 units), and incubated at 16°C for 2 h.
T4 DNA polymerase (10 units) was then added to fill in
the ends of the cDNA and incubated at 16°C for an addi-
tional 15 min. Following phenol:chloroform extraction
and ethanol precipitation, the cDNA was resuspended in
RNase-free water. Transcription was performed using
Ambion's (Austin, USA) MEGAscript reagents. A 20 μlPage 13 of 17
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buffer (1×), and 2 μl enzyme mix was incubated at 37°C
for 4 h and the primary cRNA was purified using the RNe-
asy kit (Qiagen, Chatsworth, CA) per the manufacturer's
specifications. Two hundred nanograms of the purified
cRNA were then carried forward in the secondary amplifi-
cation. Samples with less than 200 ng cRNA were concen-
trated to a 5 μl volume and the entire sample used for the
next round of amplification.
cDNA synthesis 2nd round of amplification
First-strand cDNA was synthesized by incubating the
above cRNA with 1 μg of random primers (Invitrogen,
Carlsbad, CA) at 70°C for 10 min. The reaction was then
placed on ice and the following reagents added in a 20-μL
reaction: first-strand buffer (1×), DTT (10 mM), dNTP mix
(500 μM), and Superscript III (200 units). The reaction
was incubated at 42°C for 2 h. RNase H (2 units) was
added to the reaction and incubated at 37°C for 20 min
and then heat-inactivated. The cDNA was combined with
1 μg of the T7-dT primer and incubated at 70°C for 10
min. The reaction was then placed on ice and the follow-
ing reagents added for a final volume of 150 μl: second-
strand buffer (1×), dNTP mix (200 μM), E. coli DNA
Polymerase (40 units), and then incubated at 16°C for 2
h. T4 DNA polymerase (10 units) was added to fill in the
ends of the cDNA and incubated at 16°C for an additional
15 min. The cDNA was purified with phenol:chloroform
and precipitated with ethanol.
Biotin secondary IVT
The secondary transcription reaction was performed using
the Enzo BioArray HighYield RNA kit (Affymetrix, Santa
Clara, CA). The secondary cDNA was incubated at 37°C
for 4 h in a 40 μl reaction as indicated by in the manufac-
turer recommendations and the labelled cRNA purified
using the RNeasy kit.
Array Hybridizations and Analysis
The hybridizations were performed with the Murine
Genome U74v2 Set, consisting of three GeneChip® probe
arrays (U74Av2, U74Bv2 and U74Cv2), together they
contain probe sets corresponding to approximately
36,000 full-length mouse genes and EST clusters from the
UniGene database. The biotin-labeled cRNA was frag-
mented in 40 mM Tris-acetate buffer pH 8.1 containing
100 mM potassium acetate and 30 mM Magnesium ace-
tate. 15 μg of every labelled cRNA was mixed with the
appropriate buffers and hybridized to respectively a
mouse U74Av2, U74Bv2 and U74Cv2 (Affymetrix) for 16
h at 45°C. Computer analysis of the resulting data was
performed using the dCHIP software package. Samples
were run on triplicate microarrays (three independently
cultivated, isolated and labelled WT probes and three
independently cultivated, isolated and labelled STAT3-
MER probes) and the resulting data combined into sub-
sets and compared using dCHIP. The 18 .CEL files gener-
ated by the Affymetrix Microarray Suite (MAS) were
converted in .DCP files using dCHIP. The .DCP files were
normalized and raw gene expression data generated.
Comparison was performed using the dCHIP software
wherein the three WT FVB ES cells were designated as
"baseline" (B) and the three STAT3-MER overexpressing
ES cells designated as "experiment" (E). Genes expressed
1.5 fold higher or lower in the WT versus STA3-MER cells
were then identified by defining the appropriate filtering
criteria in the dCHIP software (E/B < 1.5 or B/E > 1.5; E-B
> 100 or B-E > 100, P < 0.1, t-test). Calculations were per-
formed with both the PM/MM (perfect match/mismatch)
difference model and the PM (perfect match) only model
in order to compare the results. The microarray data is
deposited in the Gene Omnibus Repository (GEO), acces-
sion number GSE11398.
Real-Time Quantitative PCR (Q-PCR)
The total RNA from cultured ES cells was obtained using
Qiagen RNeasy mini-kit and reverse transcribed with
oligo-dT primers (Invitrogen) and SuperscriptIII (Invitro-
gen). Quantitative Real time experiments were performed
with the SyberGreen technology using the QuantiTect
SYBR kit (Qiagen) and a Rotorgene 6000 cycler (Corbett).
For quantitation of gene expression comparative Ct-
method was used after normalization with β-actin. The
following primers were used:
βactin_fwd: 5'-cat cca ggc tgt gct gtc cct gta tgc-3'
βactin_bwd: 5'-gat ctt cat ggt gct agg agc cag agc-3'
Lefty2_fwd: 5'-aca gcg cgg atg tgg agg aga tgg-3'
Lefty2_bwd: 5'-atc ctc acg gac tct cag cca ttc a-3'
Eif2s2_fwd: 5'-tac atc gtc aac cca aac atc tcc ttg c-3'
Eif2s2_bwd: 5'-ggc acg gag ctg tgc tcg ctt-3'
Dppa3_fwd: 5'-agg gtc cgc act ttg ttg tcg gtg c-3'
Dppa3_bwd: 5'-gct cct aat tct tcc cga ttt tcg cat-3'
Hexokinase2_fwd: 5'-tgt ggt ggc cgt ggt aaa tg-3'
Hexokinase2_bwd: 5'-tct tga ggc gct ctg aga tg-3'
NDP5211_fwd: 5'-cat gag cag cta cag agg aag ca-3'
NDP5211_bwd: 5'-gtg cct cag att cac tgt gta gct aa-3'
Nanog_fwd: 5'-aca agg gtc tgc tac tga gat gc-3'Page 14 of 17
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Pem/Rhox5_fwd: 5'-ctt ccg tgg aca aga gga ag-3'
Pem/Rhox5_bwd: 5'-tgt cat agc cgg cat atg tg-3'
Ppp1r15b_fwd: 5'-gcc ttc aag ctg gtc tag tc-3'
Ppp1r15b_bwd: 5'-cat cgc tat caa agc cat cg-3'
Pramel6_fwd: 5'-cag gaa gac gag tgg caa agc acg t-3'
Pramel6_bwd: 5'-agc cct gga atc tca tag cct aca tc-3'
Pramel7_fwd: 5'-gag gag aag cag aac atc agc aag a-3'
Pramel7_bwd: 5'-ctc tta gag gcg tga cat cta ggt t-3'
Stat3_fwd: 5'-ggc aag ggc ttc tcc ttc tg-3'
Stat3_bwd: 5'-agc tgc tgc ttg ttg gtg tat gg-3'
Skp2_fwd: 5'-cag ctg ctc cag act gga tg-3'
Skp2_bwd: 5'-ggt tcc ctc tgg cac gat tc-3'
Socs3_fwd: 5'-cct cca gca tct ttg tcg gaa gac-3'
Socs3_bwd: 5'-tac tga tcc agg aac tcc cga atg-3'
Trim41_fwd: 5'-tga gcc gca tgt ttt gtc agg ctg c-3'
Trim41_bwd: 5'-c aca ctt cgc gct gga cta gga gct-3'
Quantitative RT-PCR for each gene was done in triplicates
and the values were normalized to the corresponding
amounts of β-actin RNAs.
In situ hybridization
Templates for riboprobe-synthesis were obtained by
amplification through RT-PCR. Briefly, total RNA was iso-
lated from FVB/STAT3-MER ES cells cultivated in presence
of 4OHT and RT was performed with oligo-dT primers.
300–400 bp long fragments containing part of the ORF of
the genes of interest were amplified by PCR and cloned in
a pCRII® TOPO® dual promoter vector (Invitrogen). DNA
templates for riboprobe synthesis were digested with
appropriate enzymes to provide fragments for either sense
or antisense orientation of the PCR product respect to the
vector. Labelled riboprobes were synthesized by SP6 or T7
RNA polymerases by incorporation of digoxygenin-
labelled UTPs.
The embryos were transferred in a micro pore insert (12
μm) sitting in a well of a 4 well plate and fixed with freshly
prepared 4% PFA/PBS, washed twice in PBT and dehy-
drated once in 25%, 50%, 75% and twice in 100% meth-
anol/PBT. The dehydration was followed by rehydration
in the reverse order of the MeOH/PBT series 75%, 50%,
25% for 5 min each. The embryos permeabilized in RIPA
buffer and refixed in 4% PFA/0.2% glutaraldehyde. After
prehybridisation in hybridisation solution for ≥2 hours at
70°C the embryos were incubated in hybridisation solu-
tion containing 1.6 μg/ml of the corresponding ribo-
probe. As a control for the specificity of the labelling, in
each hybridization experiment control embryos were
hybridized with an equal concentration of a sense probe
transcribed from the same template as the antisense
probe. After high and low stringency washes hybridized
riboprobes were detected using an AP-coupled anti-digox-
ygenin antibodies (Roche Diagnostics, Rotkreuz, Switzer-
land) and the AP-substrate BM-Purple (Roche
Diagnostics, Rotkreuz, Switzerland). The staining reaction
was stopped by rinsing in 2 mM EDTA/PBT. Embryos
were subsequently post-fixed in 4% PFA/0.1% glutaralde-
hyde in PBT and cleared in a glycerol:PBT 1:1 solution.
Overexpression of Pramel7, Pem/Rhox5 and Nanog
The full length open reading frames (ORF) of Pramel7
and Pem/Rhox5 were amplified by RT-PCR and
sequenced. The full length cDNAs were cloned in the
pfloxedNanog expression vector [25] by exchanging the
Nanog cDNA with either the one of Pem/Rhox5 or
Pramel7. The expression vectors were completely
sequenced and finally electroporated in E14 ES cells. After
selection with puromycin single colonies were isolated
and their expression levels were determined by real time
PCR. The clones with the strongest overexpression were
chosen for further experiments.
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